INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

NCT00472771 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Terminated due to clinical trial material production delays

Conditions

Small Cell Lung Cancer

Interventions

DRUG: INNO-206

Sponsor

CytRx